Endometrial ablation devices market seen reaching $5.55 billion by 2030

The Business Research Company says the global endometrial ablation devices market will grow from $3.87 billion in 2025 to $5.55 billion by 2030. The report points to rising gynecological disorders, higher healthcare spending and more outpatient procedures as the main growth drivers.

Why it matters: - The endometrial ablation devices market is growing as demand rises for minimally invasive treatment options for abnormal uterine bleeding and related gynecological conditions. - The market’s projected expansion signals more use of outpatient procedures, single-use devices and technologies designed for faster recovery. - Women’s health innovation and broader access to gynecological care are becoming stronger commercial drivers.

What happened: - The Business Research Company released a report on the global endometrial ablation devices market. - The market was valued at $3.87 billion in 2025. - The market is forecast to reach $4.14 billion in 2026. - The report projects the market will reach $5.55 billion by 2030. - The report was published Aug. 6, 2026, from London. - Download a free sample of the report.

The details: - Endometrial ablation devices remove or destroy the uterine lining, or endometrium. - The devices are used mainly to treat abnormal uterine bleeding. - The procedures also help manage adenomyosis and endometrial hyperplasia. - The report ties market growth to more cases of abnormal uterine bleeding, wider availability of gynecological care, greater acceptance of minimally invasive techniques and advances in ablation technology. - The report also cites higher patient awareness of treatment options as a growth factor. - For the forecast period, the report points to stronger demand for outpatient gynecological procedures, next-generation devices, single-use medical technologies and faster-recovery treatments. - The report highlights growing use of radiofrequency endometrial ablation devices and a continued shift toward outpatient care. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period. - The regional analysis also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology and future trend analysis, and updated graphics and tables. - View the full report.

Between the lines: - The report frames the market as a mix of clinical need and procedure shifts, with outpatient care and single-use products shaping purchasing decisions. - Rising healthcare spending can improve access to procedures and support better treatment infrastructure, which may widen adoption. - The growth story is strongest in regions where gynecological care is expanding and minimally invasive options are becoming standard.

What's next: - The market is projected to grow at a 7.6% CAGR through 2030. - The report expects continued investment in women’s health innovations to support device adoption. - Additional gains will likely come from broader use of safer, more efficient ablation systems and more outpatient treatment settings. - The Business Research Company says its 2026 market reports also include forecasting tools and trend analysis for buyers and investors.